China Health Group Inc. (HKG:8225)
Hong Kong
· Delayed Price · Currency is HKD 0.1630
-0.0010 (-0.61%)
Jul 2, 2025, 3:29 PM HKT
China Health Group Revenue
In the year 2024, China Health Group had annual revenue of 26.45M CNY with 23.47% growth. China Health Group had revenue of 4.08M in the quarter ending December 31, 2024, with 15.56% growth.
Revenue
26.45M CNY
Revenue Growth
+23.47%
P/S Ratio
5.80
Revenue / Employee
629.86K CNY
Employees
42
Market Cap
163.24M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.45M | 5.03M | 23.47% |
| Dec 31, 2023 | 21.43M | 8.34M | 63.67% |
| Dec 31, 2022 | 13.09M | -70.51M | -84.34% |
| Dec 31, 2021 | 83.60M | 538.00K | 0.65% |
| Dec 31, 2020 | 83.06M | 19.85M | 31.40% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| Innovent Biologics | 10.03B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Sino Biopharmaceutical | 30.72B |
| Akeso | 2.26B |
| CSPC Pharmaceutical Group | 28.99B |